METTL3 and colorectal carcinoma: It downregulates overexpression of Methyltransferase-like 3 (METTL3), an enzyme implicated in promoting epithelial–mesenchymal transition and vasculogenic mimicry, thereby restricting CRC cell proliferation and invasion [103].